BlackRock Fund Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
– Sell
-8,488
Closed -$716K – 3839
2014
Q3
$716K Sell
8,488
-632
-7% -$51.1K ﹤0.01% 3205
2014
Q2
$740K Buy
9,120
+44
+0.5% +$3.46K ﹤0.01% 3172
2014
Q1
$691K Buy
9,076
+22
+0.2% +$1.6K ﹤0.01% 3219
2013
Q4
$652K Hold
9,054
– – ﹤0.01% 3214
2013
Q3
$622K Sell
9,054
-4,838
-35% -$320K ﹤0.01% 3197
2013
Q2
$880K Buy
+13,892
New +$904K ﹤0.01% 3162

Other funds holding NVS

BlackRock Fund Advisors's NVS Position: Q4 2014 in Review

BlackRock Fund Advisors sold out of Novartis (NVS) in Q4 2014, closing a stake of 8,488 shares — an estimated $716K sold.

BlackRock Fund Advisors first reported a position in NVS in Q2 2013 and held it in 6 quarters. The position peaked at $880K in Q2 2013. 919 funds tracked by Wall St. Rank hold NVS as of Q4 2014.

  • BlackRock Fund Advisors reported no remaining Novartis position as of Q4 2014 after selling out during the quarter.
  • BlackRock Fund Advisors sold 8,488 Novartis shares in Q4 2014, an estimated $716K.
  • BlackRock Fund Advisors first reported a position in Novartis in Q2 2013 and held it in 6 quarters.
  • BlackRock Fund Advisors's Novartis position peaked at $880K in Q2 2013.
  • 919 funds tracked by Wall St. Rank held Novartis as of Q4 2014.

Based on BlackRock Fund Advisors's 13F filing for Q4 2014, filed 9 Feb 2015.